The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Share News (TYR)

  • There is currently no data for TYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Indivior Execs Buy After Maiden Results

Fri, 20th Feb 2015 12:11

Director Dealings Summary - Week Ended February 20        
Company Name Position Buy or Sell Number of Shares Resulting Holding *Note
600 Group Nigel Rogers CEO Buy 150,000 1.5 million Day after issuing first tranche of loan notes
Amati VCT Charles Pinney Director Sold 6,540 29,377  
ARM Holdings Tom Lantzsch EVP Strategy Sold 54,201 48,892 Week after ARM raised  dividend & posted  increased  profit for 2014
Anglo American John Parker Chairman Buy 8,240 Undisclosed 3 days after reporting drop in earnings
Ashley House Stephen Minion Deputy Chair Buy 150,000 4.1 million  
Ashley House Christopher Lyons Chairman Buy 100,000 176,500  
Ashley House Nigel Croxford Construction Director Buy 100,000 901,530  
Ashley House Antony Walters CEO Buy 300,000 579,000  
Ashley House Jonathan Holmes Director Buy 140,000 2.1 million  
Ashley House Kate Minion HR Director Buy 37,000 459,750  
Avesco Graham Andrews Director Buy 13,000 292,183   
Blur Group David Sheriff Deputy Chairman Buy 28,500 72,600 8 days after appointed as deputy chairman
Blur Group Richard Bourne-Arton Non-Executive Buy 32,051 432,381  
City of London Investment Barry Olliff CEO Sold 250,000 2.9 million Week after reporting profit increase
Euromoney John Orchard Manager Sold 6,630 Undisclosed  
Fiske Gerard Luchini Compliance Director Buy 6,000 45,000  
Fulcrum Utility Philip Holder Chairman Buy 250,000 3 million  
Hammerson Jean-Philippe Mouton Director Sold 27,831 221,936 Same day as company reported jump in pretax profit
Helios Underwriting Nigel Hanbury CEO Buy 17,188 1.3 million Same day as it acquired Nameco for GBP900,000
Hogg Robinson Paul Williams Non-Executive Director Buy 50,000 100,000 6 days after saying it would meet market expectations for FY14
Indivior Cary Claiborne CFO Buy 62,000 85,780 2 days after Indivior posted lower pretax profit in maiden results
Indivior Debby Betz Corporate Affairs Officer Buy 8,000 15,900 On day Indivior posted lower pretax profit in maiden results
Indivior Shaun Thaxter CEO Buy 335,000 425,000 5 days after Indivior posted lower pretax profit in maiden results
IPPlus William Catchpole MD Buy 58,647 2.7 million  
IPPlus Stuart Gordon CFO Buy 14,154 1 million  
IPPlus Geoffrey Forsyth Director Buy 22,289 1.1 million  
Marks & Spencer Steve Rowe Director of Food Division Sold 109,250 160,714 Rowe sold 40% of his shareholding
Nature Group Peter Snell Non-Executive Buy 115,000 900,000  
Plastics Capital Non-Executive Andrew Walker Buy 118,771 210,646  
Qatar Investment Fund Nicholas Wilson Chairman Buy 9,500 50,000  
Redrow Will Heath Development Director Sold 13,316 Nil 8 days after doubling dividend & profit increase
Rio Tinto Megan Clark Non-Executive Buy 1,550 1,715  
Rolls Royce David Smith CFO Buy 2,226 2,376  
TyraTech James Hill Non-Executive Buy 50,000 1.2 million  
Verona Pharma Jan-Anders Karlsson  CEO Buy 1 million 2.7 million  
Vianet James Dickson Chairman Buy 10,545 25,000  
Workspace Group
 Graham Clemett CFO Sold 20,000 73,159  
  Julia Clemett   Sold 20,372    
Workspace Group
 Angus Boag Development Director Sold 80,000 311,206  
  Claire Boag   Sold 5,000    
Workspace Group
 Chris Pieroni Operations Director Sold 2,350 173,263  
  Caroline Pieroni   Sold 96,970    
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event.
When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam    
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
28 Sep 2018 14:53

TyraTech enters into merger agreement with American Vanguard Corporation

(Sharecast News) - Life sciences company TyraTech has entered into a conditional merger agreement with American Vanguard Corporation, whereby, conditional upon approval by TyraTech shareholders, AMVAC would acquire the remaining shares of common stock in TyraTech which it did not already own, for a consideration of 3.15p per share, it announced on Friday.

Read more
28 Sep 2018 11:42

TyraTech Shares Jump As 34% Shareholder Agrees To Buy Rest

LONDON (Alliance News) - Shares rose in TyraTech Inc on Friday as it reported a rise in revenue for the first half of 2018, and accepted an agreement by American Vanguard Corp to acquire all it in

Read more
23 May 2018 12:58

TyraTech 2017 Revenue Grows With New Focus On Animal Health

LONDON (Alliance News) - Life sciences company TyraTech Inc on Wednesday reported a narrowed loss for 2017 as revenue nearly doubled due to substantial growth in its product division.For a

Read more
9 May 2018 13:52

REPEAT: TyraTech Making Progress On All Operational Goals For 2018

LONDON (Alliance News) - Pest control company TyraTech Inc on Wednesday reported progress on all 2018 operational goals including products controlling parasites in production animals.The on

Read more
9 May 2018 13:52

TyraTech Making Progress On All Operational Goals For 2019

LONDON (Alliance News) - Pest control company TyraTech Inc on Wednesday reported progress on all 2018 operational goals including products controlling parasites in production animals.The on

Read more
9 Feb 2017 08:57

TyraTech Results To Meet Market View Despite US Lice Slowdown

Read more
19 Sep 2016 15:03

DIRECTOR DEALINGS: TyraTech CFO Buys 100,000 Shares

Read more
28 Jul 2016 13:24

TyraTech notessales of Vamousse progress

(ShareCast News) - Life-sciences company TyraTech said its first-half trading performance continues the upward trend from prior periods, with unit sales of the Vamousse head-lice product line continuing to progress and operating-expense efficiencies now being realised. "These trends are anticipated

Read more
28 Jul 2016 09:17

TyraTech Vamousse Sales In Line With Progress Made On Animal Health

Read more
1 Jun 2016 15:07

UK Shareholder Meetings Calendar - Next 7 Days

Read more
22 Apr 2016 13:59

DIRECTOR DEALINGS: TyraTech Non-Executive Buys Shares

Read more
15 Apr 2016 12:13

DIRECTOR DEALINGS: TyraTech Non-Executive Buys 100,000 Shares

Read more
14 Apr 2016 10:26

DIRECTOR DEALINGS: TyraTech Non-Executive Buys 250,000 Shares

Read more
12 Apr 2016 08:14

TyraTech 2015 Loss Narrows On Strong Growth For Vamousse In US And UK

Read more
11 Apr 2016 12:28

TyraTech appoints industry veteran Barella as chairman

(ShareCast News) - AIM-listed life sciences technology group TyraTech has appointed industry veteran José Geraldo Ramalho Barella as non-executive chairman with immediate effect following the resignation of Alan Reade. TyraTech said 60-year old Barella has significant global experience across the an

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.